BiomX raises $32M in Series B Financing

BioTech |  News | 0 Comment | 22 Feb, 2019

BiomX Ltd., a microbiome company developing customized phage therapies has announced the closing of a $32 million series B equity financing. The financing was led by existing investors Orbi...Read more

Generex Biotechnology Subsidiary granted approval for ECM hydrogel

BioTech |  News | 0 Comment | 21 Feb, 2019

Generex Biotechnology has announced that the company’s subsidiary Regentys Corporation, a clinical stage regenerative medicine company focused on the treatment of inflammatory bowel d...Read more

Treating diseases by redressing the microbiome balance

BioTech |  Opinion | By Brian Salmons and Walter H. Gunzburg | 1 Comment | 21 Feb, 2019

The human microbiome refers to the total genomes of micro-organisms (microbiota) inhabiting the human body, including protozoa, viruses, bacteria and yeast/fungi that live symbiotically on ...Read more

Bioblast Pharma sells its Trihalose Clinical Development to Seelos Therapeutics

BioTech |  News | 0 Comment | 21 Feb, 2019

Bioblast Pharma, a clinical-stage, orphan disease-focused biotechnology company headquartered in Israel, has announced the sale of its Trehalose clinical development programs (including its...Read more

Korean govt to inject $2.6B to develop biotech in 2019

BioTech |  News | 0 Comment | 20 Feb, 2019

According to reports from the Korean Herald,  the government of Korea will spend 2.93 trillion won (US$2.61 billion) this year to develop new biotechnology, as part of efforts to becom...Read more

AGC Biologics, Calypso Biotech sign pact for cGMP manufacturing

BioTech |  News | 0 Comment | 21 Feb, 2019

AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, and Calypso Biotech B.V. (Calypso), a biotechnology company focused on the development of no...Read more

Merck gets first U.S. Patent for improved CRISPR technology

BioTech |  News | 0 Comment | 20 Feb, 2019

Merck, a leading science and technology company and leader in genome editing, announced that the United States Patent and Trademark Office has issued a formal notice allowing Merck's p...Read more

EMA completes inspection of cGMP DS and DP facilities at WuXi Biologics

BioTech |  News | 0 Comment | 19 Feb, 2019

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that the E...Read more

Bharat Biotech acquires Chiron Behring Vaccines

BioTech |  News | 0 Comment | 18 Feb, 2019

Bharat Biotech has announced the forthcoming acquisition of Chiron Behring Vaccines Pvt Ltd, located in Ankleshwar, Gujarat from GlaxoSmithKline Asia. Bharat Biotech will acquire 100% equit...Read more

NCCS , Lucence predict immunotherapy response for kidney cancer

BioTech |  News | 0 Comment | 18 Feb, 2019

Immunotherapy drugs such as PD-L1 checkpoint inhibitors represent the front-line treatment for kidney cancer. But immunotherapy is expensive, benefits only a subset of patients and is futil...Read more

Burning Rock completes Series C financing of RMB 850M

BioTech |  News | 0 Comment | 15 Feb, 2019

Burning Rock recently held the signing ceremony and announced the closing of the Series C financing totaling RMB 850 million. The financing was led by GIC, followed by LYFE Capital, CMB Int...Read more

3SBio and Verseau team up for Immuno-Oncology Therapies

BioTech |  News | 0 Comment | 13 Feb, 2019

3SBio and Verseau Therapeutics have announced a partnership agreement focused on the development and commercialization of novel monoclonal antibodies in the field of immuno-oncology for a b...Read more

Takeda receives EC approval to extend the marketing authorization for ADCETRIS

BioTech |  News | 0 Comment | 12 Feb, 2019

Seattle Genetics, Inc. has announced that its collaborator, Takeda Pharmaceutical Company Limited, received approval from the European Commission (EC) to extend the marketing authorization ...Read more

Bridge Bio presents Preclinical, Ph I study results for BBT-401

BioTech |  News | 0 Comment | 12 Feb, 2019

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, announced that the company presented the preclinical and the Phase I study results for ...Read more

ROOT OF SKIN sells out for fifth consecutive time on QVC Japan

BioTech |  News | 0 Comment | 12 Feb, 2019

AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, has announced that the Company's revolutionary stem-cell based ROOT OF SKIN™ skincare lin...Read more

Kiran Mazumdar Shaw inducted to the National Academy of Engineering

BioTech |  News | 0 Comment | 08 Feb, 2019

Kiran Mazumdar-Shaw, Chairperson and Managing Director, Biocon Ltd has been elected as a member of the prestigious U.S.-based National Academy of Engineering (NAE) for her contribution to t...Read more

EdiGene raises $10M in Series pre-B

BioTech |  News | 0 Comment | 06 Feb, 2019

EdiGene Inc., headquartered in Beijing, with operational subsidiaries in Guangzhou, China and Cambridge, USA and which develops genome editing technologies into novel therapeutics for a bro...Read more

ProteoNic Biotechnology Licenses Protein Production Technology to Eli Lilly and Company

BioTech |  News | 0 Comment | 05 Feb, 2019

ProteoNic Biotechnology BV has announced that it licensed its 2G UNic technology for boosting recombinant protein production to Eli Lilly and Company. Under the agreement, Lilly gains non-...Read more